Back

Systemic versus site targeted treatment of neoatherosclerosis.

28 August 2017 (16:10 - 16:20)
Organised by:
Congress Presentation Part of: ESC Grants for Medical Research Innovation Atherosclerosis ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Michael Joner

German Heart Center Muenchen Technical University of Munich, Munich (Germany)

4 More presentations in this session

Presentation thumbnail
Modeling the Individual Risk of Thrombosis in Oncology (MIRTO).
Doctor J. Soria Fernandez (Sant Pau, ES)
Slides Video
Presentation thumbnail
The importance of type of antithrombotic treatment after aortic valve replacement for the risk of future thromboembolic and bleeding events in aortic stenosis - Comparison of mechanical -, bio prosthetic and trans-catheter (TAVI) aortic valve replacement.
Professor C. Christersson (Uppsala, SE)
Slides Video
Presentation thumbnail
Dual approach cardiac MRI for molecular assessment and interventional treatment of vulnerable coronary plaques in a porcine model.
Professor T. Heidt (Buhl, DE)
Slides Video
Presentation thumbnail
Identification of mirRNA profiles associated with venous thromboembolism and recurrent events (IMPROVEMENTS).
Doctor D. Tregouet (Paris, FR)
Slides Video

Access the full session

Session thumbnail
ESC Grants for Medical Research Innovation

The Event

Event poster

ESC Congress 2017

28 August 2017 16:10 CET
You may be interested in
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022
thumbnail
Congress Presentation
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
1 September 2025
thumbnail
Congress Session
Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources